Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - paracetamol; phenylephrine hydrochloride - powder for oral solution - 500 mg/12.2 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - phenylephrine hydrochloride; paracetamol - powder for oral solution - 1000 mg/12.2 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Greece - English - HMA (Heads of Medicines Agencies)

sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium

France - English - HMA (Heads of Medicines Agencies)

sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium

Hungary - English - HMA (Heads of Medicines Agencies)

sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium

Italy - English - HMA (Heads of Medicines Agencies)

sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium

Portugal - English - HMA (Heads of Medicines Agencies)

sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium

Romania - English - HMA (Heads of Medicines Agencies)

sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium

United States - English - NLM (National Library of Medicine)

par pharmaceutical - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg in 5 ml - valproic acid oral solution is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid oral solution is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precautions (5.1)   for statement regarding fatal hepatic dysfunction. because of the risk to the fetus of decreased iq, neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless th

United States - English - NLM (National Library of Medicine)

cardinal health - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg in 5 ml - valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precaution (5.1) for statement regarding fatal hepatic dysfunction. because of the risk to the fetus of decreased iq, neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless the drug is essential to the man